Share

October 2022; 8 (5) Clinical/Scientific NoteOpen Access

Filamin A Variant as a Possible Second-Hit Gene Promoting Moyamoya Disease–like Vascular Formation Associated With RNF213 p.R4810K Variant

Yasuhito Ikeuchi, Jiro Kitayama, Noriyuki Sahara, Takuya Okata, Noriko Miyake, Naomichi Matsumoto, Takanari Kitazono, Tetsuro Ago
First published September 9, 2022, DOI: https://doi.org/10.1212/NXG.0000000000200017
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
422

Share

Article Information

vol. 8 no. 5 e200017
DOI: 
https://doi.org/10.1212/NXG.0000000000200017
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2376-7839
History: 
  • Received April 18, 2022
  • Accepted in final form June 30, 2022
  • First Published September 9, 2022.
Copyright & Usage: 
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Yasuhito Ikeuchi, MD* (ikeuchi12004{at}gmail.com),
    2. Jiro Kitayama, MD, PhD* (j-kitayama{at}fukuoka-med.jrc.or.jp),
    3. Noriyuki Sahara, MD (nori.s0127{at}gmail.com),
    4. Takuya Okata, MD (rimata2585{at}gmail.com),
    5. Noriko Miyake, MD, PhD (nomiyake{at}ri.ncgm.go.jp),
    6. Naomichi Matsumoto, MD, PhD (naomat{at}yokohama-cu.ac.jp),
    7. Takanari Kitazono, MD, PhD (kitazono.takanari.362{at}m.kyushu-u.ac.jp) and
    8. Tetsuro Ago, MD, PhD
  1. Yasuhito Ikeuchi, MD* (ikeuchi12004{at}gmail.com),
  2. Jiro Kitayama, MD, PhD* (j-kitayama{at}fukuoka-med.jrc.or.jp),
  3. Noriyuki Sahara, MD (nori.s0127{at}gmail.com),
  4. Takuya Okata, MD (rimata2585{at}gmail.com),
  5. Noriko Miyake, MD, PhD (nomiyake{at}ri.ncgm.go.jp),
  6. Naomichi Matsumoto, MD, PhD (naomat{at}yokohama-cu.ac.jp),
  7. Takanari Kitazono, MD, PhD (kitazono.takanari.362{at}m.kyushu-u.ac.jp) and
  8. Tetsuro Ago, MD, PhD
  1. From the Department of Neurology (Y.I., J.K., N.S., T.O.), Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan; Department of Human Genetics (N. Miyake, N. Matsumoto), Yokohama City University Graduate School of Medicine, Yokohama, Japan; Department of Human Genetics (N. Miyake), Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Department of Medicine and Clinical Science (T.K., T.A.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  1. Correspondence
    Dr. Ago ago.tetsuro.544{at}m.kyushu-u.ac.jp

Article usage

Article usage: September 2022 to October 2023

AbstractFullPdfSource
Sep 20227643107Highwire
Oct 2022426260Highwire
Nov 2022916053Highwire
Dec 202227725Highwire
Jan 202347520Highwire
Feb 202326415Highwire
Mar 202335120Highwire
Apr 20232438Highwire
May 202304628Highwire
Jun 202334624Highwire
Jul 202304321Highwire
Aug 202323316Highwire
Sep 202363716Highwire
Oct 20230579Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me